These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 27067179)

  • 1. Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.
    Moses K; Brandau S
    Semin Immunol; 2016 Apr; 28(2):187-96. PubMed ID: 27067179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity.
    Tumino N; Besi F; Martini S; Di Pace AL; Munari E; Quatrini L; Pelosi A; Fiore PF; Fiscon G; Paci P; Scordamaglia F; Covesnon MG; Bogina G; Mingari MC; Moretta L; Vacca P
    Front Immunol; 2021; 12():803014. PubMed ID: 35116033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasticity of myeloid-derived suppressor cells in cancer.
    Tcyganov E; Mastio J; Chen E; Gabrilovich DI
    Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression.
    Dumitru CA; Lang S; Brandau S
    Semin Cancer Biol; 2013 Jun; 23(3):141-8. PubMed ID: 23485549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diversity of circulating neutrophils in cancer.
    Mishalian I; Granot Z; Fridlender ZG
    Immunobiology; 2017 Jan; 222(1):82-88. PubMed ID: 26874580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?
    Brandau S; Moses K; Lang S
    Semin Cancer Biol; 2013 Jun; 23(3):171-82. PubMed ID: 23459190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy.
    Rapoport BL; Steel HC; Theron AJ; Smit T; Anderson R
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32244751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
    Ostrand-Rosenberg S; Fenselau C
    J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization.
    Groth C; Weber R; Lasser S; Özbay FG; Kurzay A; Petrova V; Altevogt P; Utikal J; Umansky V
    Int J Cancer; 2021 Nov; 149(9):1628-1638. PubMed ID: 34224592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils in cancer.
    Treffers LW; Hiemstra IH; Kuijpers TW; van den Berg TK; Matlung HL
    Immunol Rev; 2016 Sep; 273(1):312-28. PubMed ID: 27558343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and/or granulocytic myeloid derived suppressor cells.
    Seddon A; Hock B; Miller A; Frei L; Pearson J; McKenzie J; Simcock J; Currie M
    J Dermatol Sci; 2016 Aug; 83(2):124-30. PubMed ID: 27160951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment.
    Zhang Y; Guoqiang L; Sun M; Lu X
    Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated neutrophils: friend or foe?
    Fridlender ZG; Albelda SM
    Carcinogenesis; 2012 May; 33(5):949-55. PubMed ID: 22425643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-Faced Roles of Tumor-Associated Neutrophils in Cancer Development and Progression.
    Mukaida N; Sasaki SI; Baba T
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair.
    Aarts CEM; Hiemstra IH; Béguin EP; Hoogendijk AJ; Bouchmal S; van Houdt M; Tool ATJ; Mul E; Jansen MH; Janssen H; van Alphen FPJ; de Boer JP; Zuur CL; Meijer AB; van den Berg TK; Kuijpers TW
    Blood Adv; 2019 Nov; 3(22):3562-3574. PubMed ID: 31738831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid derived-suppressor cells: their role in cancer and obesity.
    Ostrand-Rosenberg S
    Curr Opin Immunol; 2018 Apr; 51():68-75. PubMed ID: 29544121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).
    Alfaro C; Teijeira A; Oñate C; Pérez G; Sanmamed MF; Andueza MP; Alignani D; Labiano S; Azpilikueta A; Rodriguez-Paulete A; Garasa S; Fusco JP; Aznar A; Inogés S; De Pizzol M; Allegretti M; Medina-Echeverz J; Berraondo P; Perez-Gracia JL; Melero I
    Clin Cancer Res; 2016 Aug; 22(15):3924-36. PubMed ID: 26957562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity.
    Yoshida M; Taguchi A; Kawana K; Ogishima J; Adachi K; Kawata A; Nakamura H; Sato M; Fujimoto A; Inoue T; Tomio K; Mori M; Nagamatsu T; Arimoto T; Koga K; Hiraike OW; Oda K; Kiyono T; Osuga Y; Fujii T
    Int J Oncol; 2018 Oct; 53(4):1580-1590. PubMed ID: 30066851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Marrow Neutrophils of Multiple Myeloma Patients Exhibit Myeloid-Derived Suppressor Cell Activity.
    Petersson J; Askman S; Pettersson Å; Wichert S; Hellmark T; Johansson ÅCM; Hansson M
    J Immunol Res; 2021; 2021():6344344. PubMed ID: 34414242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.
    Ortiz-Espinosa S; Morales X; Senent Y; Alignani D; Tavira B; Macaya I; Ruiz B; Moreno H; Remírez A; Sainz C; Rodriguez-Pena A; Oyarbide A; Ariz M; Andueza MP; Valencia K; Teijeira A; Hoehlig K; Vater A; Rolfe B; Woodruff TM; Lopez-Picazo JM; Vicent S; Kochan G; Escors D; Gil-Bazo I; Perez-Gracia JL; Montuenga LM; Lambris JD; Ortiz de Solorzano C; Lecanda F; Ajona D; Pio R
    Cancer Lett; 2022 Mar; 529():70-84. PubMed ID: 34971753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.